Zevra Therapeutics to Report Fourth Quarter and Full-Year 2022 Results

Rhea-AI Summary

Zevra Therapeutics, formerly KemPharm, Inc. (NasdaqGS: KMPH), has announced a conference call scheduled for March 7, 2023, at 8:30 a.m. ET. The call will cover the company's corporate and financial results for Q4 and full-year 2022. Investors can access the live audio webcast through the Investor Relations section on the company’s website, with an archive available for 90 days post-event. Participants can also join the call by dialing (800) 343-4849 (U.S.) or +1 (203) 518-9848 (International) using Conference ID: ZVRAQ422. Zevra focuses on developing therapies for rare diseases, leveraging data-driven approaches to address unmet medical needs.

CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (Zevra, or the Company, formerly KemPharm, Inc.), a rare disease therapeutics company, has announced that the Company will host a conference call and live audio webcast on Tuesday, March 7, 2023, at 8:30 a.m. ET, to discuss its corporate and financial results for the fourth quarter and full-year 2022.

The audio webcast with a slide presentation will be accessible via the Investor Relations section of the Company’s website, http://investors.zevra.com/. An archive of the webcast and presentation will be available for 90 days beginning at approximately 9:30 a.m. ET, on March 7, 2023.

Additionally, interested participants and investors may access the conference call by dialing either:

• (800) 343-4849 (U.S.)
• +1 (203) 518-9848 (International)
• Conference ID: ZVRAQ422
  

About Zevra

Zevra Therapeutics is a rare disease company melding science, data, and patient need to create transformational therapies for diseases with limited or no treatment options. With unique, data-driven clinical, regulatory, and commercialization strategies, the Company is overcoming complex drug development challenges to bring much-needed therapies to patients.

Contacts 

Nichol Ochsner
+1 (732) 754-2545
nochsner@zevra.com

Jennifer Arcure
+1 (917) 603-0681
Jennifer.arcure@evokegroup.com

FAQ

What is the date and time of Zevra Therapeutics' conference call regarding KMPH?

The conference call will take place on March 7, 2023, at 8:30 a.m. ET.

How can I access the KMPH conference call?

You can access the conference call by dialing (800) 343-4849 (U.S.) or +1 (203) 518-9848 (International) with Conference ID: ZVRAQ422.

Where can I find the audio webcast for KMPH's financial results?

The audio webcast can be found in the Investor Relations section of Zevra's website.

Will the KMPH conference call be available for replay?

Yes, an archive of the conference call will be available for 90 days starting at approximately 9:30 a.m. ET on March 7, 2023.

What does Zevra Therapeutics focus on?

Zevra Therapeutics focuses on developing treatments for rare diseases that lack effective therapies.